Program Officer – Licensure and Regulatory Policy Assessment, seconded to the Michigan Department of Licensing and Regulatory Affairs
Vital Strategies, headquartered in New York City, is an international public health organization. Our programs strengthen public health systems and address the world’s leading causes of illness, injury and death. We currently work in 73 countries, supporting data-driven decision making in government, advancing evidence-based public health policies and mounting strategic communication campaigns. Vital Strategies’ priorities are driven by the greatest potential to improve and save lives. They include non-communicable disease prevention, cardiovascular health promotion, tobacco control, road safety, obesity prevention, epidemic prevention, environmental health, vital statistics systems building and multi-drug resistant tuberculosis treatment research. Our programs are concentrated in low-and middle-income countries and cities in Africa, Latin America, Asia and the Pacific. Please visit our website at www.vitalstrategies.orgto find out more about our work.Vital Strategies is seeking to add expertise in drug strategy, with specific focus on overdose prevention. This work will begin initially in the United States.
Vital Strategies offers highly competitive compensation and comprehensive benefits. Vital welcomes and supports a diverse, inclusive work environment. As such, our commitment is to promote equal employment opportunities (EEO) for all applicants seeking employment.
Vital Strategies is seeking qualified candidates for the position of Program Officer – Licensure and Regulatory Policy Assessment, seconded to the Michigan Department of Licensing and Regulatory Affairs (LARA) in Lansing, Michigan.
The Michigan Department of Licensing and Regulatory Affairs (LARA), Bureau of Community and Health Systems oversees licensure for substance use disorder (SUD) service programs. Streamlined rules for SUD program licensure went into effect in December 2018. These were the first major changes to the rules in the last several decades. The secondee will assist the Bureau in evaluating the impact of the newly promulgated rules--with an emphasis on accessibility and availability of medications for opioid use disorder (MOUD)--and make recommendations for policy/regulatory change to promote evidence-based SUD services.
The Secondee shall conduct work as if the Secondee were a full-time employee of LARA and shall have the following duties: